Xenon Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference

Rhea-AI Summary

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) announced its participation in the virtual SVB Securities Global Biopharma Conference from February 14-16, 2023. A key event will be a fireside chat on February 15, 2023, at 3:00 PM ET, featuring Ian Mortimer, President and CEO, and Sherry Aulin, CFO.

A live webcast will be available on their website, with a replay posted after the event. Xenon focuses on developing innovative therapeutics for neurological disorders, particularly epilepsy. More information can be found at www.xenon-pharma.com.

BURNABY, British Columbia, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the virtual SVB Securities Global Biopharma Conference taking place from February 14-16, 2023.

Company Fireside Chat Presentation Details:
Date:	Wednesday, February 15, 2023
Time:	3:00 pm Eastern Time (12:00 pm Pacific Time)
Presenters:	Ian Mortimer, President and CEO
	Sherry Aulin, CFO
Webcast:	Link to pre-register for the webcast can be found here.

A live webcast of the company presentation will be available on the “Investors” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com

FAQ

When will Xenon Pharmaceuticals present at the SVB Securities Global Biopharma Conference?

Xenon Pharmaceuticals will present at the conference on February 15, 2023.

What time will Xenon's fireside chat take place during the conference?

The fireside chat will be held at 3:00 PM Eastern Time on February 15, 2023.

Who will present at the fireside chat for Xenon Pharmaceuticals?

The presenters will be Ian Mortimer, President and CEO, and Sherry Aulin, CFO.

Where can I watch the webcast of Xenon Pharmaceuticals' presentation?

The webcast can be viewed on Xenon Pharmaceuticals' website under the 'Investors' section.

What is the focus of Xenon Pharmaceuticals' research?

Xenon Pharmaceuticals focuses on developing therapeutics for neurological disorders, with an emphasis on epilepsy.